Breast Cancer, the reason for increased mortality within women in a population. Have you ever wondered even though the presence of advanced technologies in medical assessments, why yet the disease is not treated and leads to death?
There are different treatments available for Breast cancer, which specifically depends on the cancer type, stage and different factors of cancer. Breast cancer is the majority diagnosed at the early stage and the is treated in view of cancer cure and prolonging cancer-free survival. The standard local treatment option is surgery and/or radiation along with an adjuvant systemic therapy, which are Chemotherapy, Endocrine therapy, and Biological targeted therapy.
Among which chemotherapy is recommended by many oncologists since it is considered as a gold standard treatment plan for cancer. Many chemotherapy drugs are available for treating breast cancer, which is beneficial for curing the disease and prolonging cancer-free survival. Although many patients opt for chemotherapy knowing the side effects and consequences unwilling.
As patients are you scared for undergoing chemotherapy, do you want to skip chemotherapy? Do you wonder can you do that? How can you be assured about skipping the chemotherapy?
The research advancement in the diagnosis of a disease has enabled us today to assure our treatment plans. Endopredict is one of those diagnostic tests that would assure you about your treatment plan. It would classify you into low risk or high-risk category, and suggest you whether you can skip chemotherapy as a treatment option and if you have to opt for chemotherapy, what are its absolute predictive benefits for prolonging long term cancer survival, as there should not be any recurrence, as my previous blog ‘Why get 5 or 10 years when you can get 15’ suggests for a 15 years recurrence analysis, which is also answered by Endopredict test.
So now you wonder if not chemotherapy then how would you treat your breast cancer and prevent a recurrence. Endocrine therapy (i.e hormonal therapy), which is available for the hormonal receptor (ER, PR) positive breast cancer individuals. It is the therapy that is usually taken for 5 years as a treatment plan, but it can be extended beyond 5 years. Endopredict would report you if you can safely be treated with endocrine therapy alone, and even if you can safely avoid extended endocrine treatment with respect to the recurrence rate of 15 years.
Endopredict is the only test available and approved by different cancer society’s (Blog: EndoPredict Shines Bright..Healthcare Biggies Furthers the Green Flag for It!), that gives you an exact treatment plan and the recurrence percentage of the breast cancer.